Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overcoming a bid by Biogen to ...

AbbVie's IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication psoriasis, but has leapfrogged into first place in Crohn's disease after getting approval for the new indication ...

BioLineRx Ltd. , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December ...

Fampridine, which is approved to improve walking in MS patients, and Ocrevus may help ease walking impairments, a review of ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Antibody therapies are critical in treating various diseases such as cancer and ...